New product license for pain killers top 265 last year

Published: 2010-08-09 07:00:00

Updated: 2010-08-09 07:00:00

Domestic drug makers are still keen on the development of antipyretics, analgesics and anti-inflammatory agents (therapeutic category number: 114), even in midst of steep decline in newly approved medicines due to implementation of mandatory validation system.

According to the Korea Food and D...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK